SLS SELLAS Life Sciences Group, Inc.

8-K Current Report

Filed: March 11, 2026

Health Care

Pharmaceutical Preparations

SELLAS Life Sciences Group, Inc. Overview

SELLAS Life Sciences Group, Inc. (SLS) 8-K current report filed with SEC EDGAR on March 11, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 8.01: Other Events

AI Filing Analysis
8-K

Item 8.01 · Other Events

• Total warrant exercise proceeds ~$42.6M since Dec 31, 2025 ($26.5M reported Jan 8 + additional $16.1M since)
• Share count now 179.5M as of March 11, 2026 — significant dilution from warrant exercises

+2 more insights

Other SELLAS Life Sciences Group, Inc. 8-K Filings

8-K Mar 19, 2026

Get deeper insights on SELLAS Life Sciences Group, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.